Libiolan en es it fr

Libiolan Brand names, Libiolan Analogs

Libiolan Brand Names Mixture

  • No information avaliable

Libiolan Chemical_Formula


Libiolan RX_link

No information avaliable

Libiolan fda sheet

Libiolan msds (material safety sheet)

Libiolan Synthesis Reference

No information avaliable

Libiolan Molecular Weight

309.469 g/mol

Libiolan Melting Point

< 25 oC

Libiolan H2O Solubility

Soluble as HCl salt

Libiolan State


Libiolan LogP


Libiolan Dosage Forms

Tablets (oral, 1 mg)

Libiolan Indication

Used for the symptomatic treatment of parkinsonism.

Libiolan Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Libiolan Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Libiolan side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Libiolan Patient Information

Libiolan Organisms Affected

Humans and other mammals